

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | indole-containing compound catabolic process (GO:0042436) | 5.87991333 |
| 2 | indolalkylamine catabolic process (GO:0046218) | 5.87991333 |
| 3 | tryptophan catabolic process (GO:0006569) | 5.87991333 |
| 4 | aromatic amino acid family catabolic process (GO:0009074) | 5.57411299 |
| 5 | tryptophan metabolic process (GO:0006568) | 5.36175172 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 5.23931437 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.23931437 |
| 8 | cellular biogenic amine catabolic process (GO:0042402) | 4.79770504 |
| 9 | amine catabolic process (GO:0009310) | 4.79770504 |
| 10 | kynurenine metabolic process (GO:0070189) | 4.79289306 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.64781023 |
| 12 | L-phenylalanine metabolic process (GO:0006558) | 4.64781023 |
| 13 | NAD biosynthetic process (GO:0009435) | 4.42408754 |
| 14 | indolalkylamine metabolic process (GO:0006586) | 4.37888833 |
| 15 | regulation of fibrinolysis (GO:0051917) | 4.12330663 |
| 16 | phospholipid efflux (GO:0033700) | 4.11929288 |
| 17 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.09493656 |
| 18 | high-density lipoprotein particle remodeling (GO:0034375) | 4.05197986 |
| 19 | bile acid biosynthetic process (GO:0006699) | 4.04543937 |
| 20 | aromatic amino acid family metabolic process (GO:0009072) | 4.02667807 |
| 21 | blood coagulation, intrinsic pathway (GO:0007597) | 3.97534060 |
| 22 | urea cycle (GO:0000050) | 3.92334395 |
| 23 | urea metabolic process (GO:0019627) | 3.92334395 |
| 24 | regulation of cholesterol esterification (GO:0010872) | 3.90132281 |
| 25 | tyrosine metabolic process (GO:0006570) | 3.77525888 |
| 26 | glyoxylate metabolic process (GO:0046487) | 3.74998223 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 3.67911308 |
| 28 | bile acid and bile salt transport (GO:0015721) | 3.65168301 |
| 29 | bile acid metabolic process (GO:0008206) | 3.60211337 |
| 30 | low-density lipoprotein particle remodeling (GO:0034374) | 3.55689822 |
| 31 | imidazole-containing compound metabolic process (GO:0052803) | 3.54116275 |
| 32 | negative regulation of lipase activity (GO:0060192) | 3.53974151 |
| 33 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.53758942 |
| 34 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.53758942 |
| 35 | protein carboxylation (GO:0018214) | 3.50940003 |
| 36 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.50940003 |
| 37 | cellular glucuronidation (GO:0052695) | 3.48806815 |
| 38 | plasma lipoprotein particle remodeling (GO:0034369) | 3.44160709 |
| 39 | protein-lipid complex remodeling (GO:0034368) | 3.44160709 |
| 40 | macromolecular complex remodeling (GO:0034367) | 3.44160709 |
| 41 | homocysteine metabolic process (GO:0050667) | 3.43426933 |
| 42 | serine family amino acid catabolic process (GO:0009071) | 3.41788948 |
| 43 | aldehyde catabolic process (GO:0046185) | 3.41539716 |
| 44 | triglyceride homeostasis (GO:0070328) | 3.34415723 |
| 45 | acylglycerol homeostasis (GO:0055090) | 3.34415723 |
| 46 | regulation of protein activation cascade (GO:2000257) | 3.34214576 |
| 47 | complement activation, alternative pathway (GO:0006957) | 3.33243803 |
| 48 | arginine metabolic process (GO:0006525) | 3.29811650 |
| 49 | amino-acid betaine metabolic process (GO:0006577) | 3.27637806 |
| 50 | regulation of activation of Janus kinase activity (GO:0010533) | 3.25729817 |
| 51 | cholesterol efflux (GO:0033344) | 3.25406121 |
| 52 | reverse cholesterol transport (GO:0043691) | 3.24857918 |
| 53 | negative regulation of fibrinolysis (GO:0051918) | 3.23713959 |
| 54 | alpha-amino acid catabolic process (GO:1901606) | 3.21818326 |
| 55 | uronic acid metabolic process (GO:0006063) | 3.21210877 |
| 56 | glucuronate metabolic process (GO:0019585) | 3.21210877 |
| 57 | fibrinolysis (GO:0042730) | 3.17239814 |
| 58 | coenzyme catabolic process (GO:0009109) | 3.12391986 |
| 59 | benzene-containing compound metabolic process (GO:0042537) | 3.08621778 |
| 60 | nucleotide transmembrane transport (GO:1901679) | 3.07040831 |
| 61 | regulation of complement activation (GO:0030449) | 2.99418850 |
| 62 | linoleic acid metabolic process (GO:0043651) | 2.99008773 |
| 63 | regulation of bile acid biosynthetic process (GO:0070857) | 2.94838630 |
| 64 | indole-containing compound metabolic process (GO:0042430) | 2.92446865 |
| 65 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.91276433 |
| 66 | omega-hydroxylase P450 pathway (GO:0097267) | 2.90995022 |
| 67 | protein activation cascade (GO:0072376) | 2.87578845 |
| 68 | polyol transport (GO:0015791) | 2.86549755 |
| 69 | fatty acid elongation (GO:0030497) | 2.81883746 |
| 70 | regulation of triglyceride catabolic process (GO:0010896) | 2.78469616 |
| 71 | superoxide anion generation (GO:0042554) | 2.78263148 |
| 72 | cellular amino acid catabolic process (GO:0009063) | 2.77486232 |
| 73 | cofactor catabolic process (GO:0051187) | 2.77468356 |
| 74 | detection of bacterium (GO:0016045) | 2.74870376 |
| 75 | drug catabolic process (GO:0042737) | 2.74308554 |
| 76 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.71595663 |
| 77 | arginine catabolic process (GO:0006527) | 2.69966936 |
| 78 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.68745201 |
| 79 | androgen biosynthetic process (GO:0006702) | 2.68692273 |
| 80 | opsonization (GO:0008228) | 2.68244169 |
| 81 | negative regulation of sterol transport (GO:0032372) | 2.67623096 |
| 82 | negative regulation of cholesterol transport (GO:0032375) | 2.67623096 |
| 83 | intestinal cholesterol absorption (GO:0030299) | 2.67560622 |
| 84 | sulfur amino acid catabolic process (GO:0000098) | 2.63005929 |
| 85 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.62731274 |
| 86 | negative regulation of blood coagulation (GO:0030195) | 2.61505698 |
| 87 | negative regulation of hemostasis (GO:1900047) | 2.61505698 |
| 88 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.61146349 |
| 89 | regulation of phospholipase A2 activity (GO:0032429) | 2.60997101 |
| 90 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.58036299 |
| 91 | pyridine-containing compound biosynthetic process (GO:0072525) | 2.56775314 |
| 92 | detection of other organism (GO:0098543) | 2.56485326 |
| 93 | plasma lipoprotein particle assembly (GO:0034377) | 2.55522259 |
| 94 | regulation of interleukin-8 secretion (GO:2000482) | 2.54870030 |
| 95 | cellular ketone body metabolic process (GO:0046950) | 2.50578407 |
| 96 | plasma lipoprotein particle organization (GO:0071827) | 2.50523427 |
| 97 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.49165157 |
| 98 | plasma lipoprotein particle clearance (GO:0034381) | 2.48924720 |
| 99 | adenosine metabolic process (GO:0046085) | 2.48245829 |
| 100 | organic acid catabolic process (GO:0016054) | 2.47025351 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.57081792 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.94495757 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.17570006 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.84436326 |
| 5 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.66677886 |
| 6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.60919521 |
| 7 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.60223674 |
| 8 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.60132690 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.51005192 |
| 10 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.43085175 |
| 11 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 2.39483982 |
| 12 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 2.33358732 |
| 13 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.32783370 |
| 14 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.30645264 |
| 15 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.29360949 |
| 16 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.16408269 |
| 17 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.11452835 |
| 18 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.10375612 |
| 19 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 2.07979945 |
| 20 | VDR_22108803_ChIP-Seq_LS180_Human | 2.06196122 |
| 21 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.03752977 |
| 22 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 2.02417247 |
| 23 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.86020842 |
| 24 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.85430238 |
| 25 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.81209213 |
| 26 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.80775053 |
| 27 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.79998386 |
| 28 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.73867083 |
| 29 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.72465214 |
| 30 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.71099348 |
| 31 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.70800855 |
| 32 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.67821370 |
| 33 | P300_19829295_ChIP-Seq_ESCs_Human | 1.66731741 |
| 34 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.66606954 |
| 35 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.65663452 |
| 36 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.64529864 |
| 37 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.64143259 |
| 38 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.63362111 |
| 39 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 1.62658502 |
| 40 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.59391951 |
| 41 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.54280619 |
| 42 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.53825240 |
| 43 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.52152475 |
| 44 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.52047084 |
| 45 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.50898158 |
| 46 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.50687128 |
| 47 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.50280991 |
| 48 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.48963263 |
| 49 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.48610671 |
| 50 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.47986136 |
| 51 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.47824474 |
| 52 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.47742853 |
| 53 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.46592094 |
| 54 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.44489101 |
| 55 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.41930351 |
| 56 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.38751549 |
| 57 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.38304979 |
| 58 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.37689985 |
| 59 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.36502531 |
| 60 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.32820453 |
| 61 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.32206453 |
| 62 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.32065613 |
| 63 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.28052729 |
| 64 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.27994653 |
| 65 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.27989485 |
| 66 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.24413808 |
| 67 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.20125942 |
| 68 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18941982 |
| 69 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.18719839 |
| 70 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.17185563 |
| 71 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.15768716 |
| 72 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.13951872 |
| 73 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.13776208 |
| 74 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.13772986 |
| 75 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.13639017 |
| 76 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.13219411 |
| 77 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.13219212 |
| 78 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.13136624 |
| 79 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.12915820 |
| 80 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.12311664 |
| 81 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.11531347 |
| 82 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.11467876 |
| 83 | FUS_26573619_Chip-Seq_HEK293_Human | 1.08706420 |
| 84 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.08335646 |
| 85 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.07447433 |
| 86 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.03766249 |
| 87 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.03123585 |
| 88 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.01912268 |
| 89 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.01608550 |
| 90 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.01540272 |
| 91 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99948334 |
| 92 | KDM2B_26808549_Chip-Seq_REH_Human | 0.97782665 |
| 93 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.97751697 |
| 94 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.96388702 |
| 95 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95457559 |
| 96 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.95180907 |
| 97 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95180907 |
| 98 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.94639462 |
| 99 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.94544771 |
| 100 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.93632416 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.25659549 |
| 2 | MP0005360_urolithiasis | 4.97524442 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.58896731 |
| 4 | MP0005365_abnormal_bile_salt | 4.00126535 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.58144731 |
| 6 | MP0004381_abnormal_hair_follicle | 3.39468048 |
| 7 | MP0000566_synostosis | 3.23037242 |
| 8 | MP0006292_abnormal_olfactory_placode | 3.10300850 |
| 9 | MP0003195_calcinosis | 3.06071516 |
| 10 | MP0005451_abnormal_body_composition | 2.96736130 |
| 11 | MP0003941_abnormal_skin_development | 2.89010696 |
| 12 | MP0003252_abnormal_bile_duct | 2.70203250 |
| 13 | MP0002102_abnormal_ear_morphology | 2.45977556 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.30647591 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.19968106 |
| 16 | MP0003136_yellow_coat_color | 2.16649889 |
| 17 | MP0001188_hyperpigmentation | 2.15783081 |
| 18 | MP0009697_abnormal_copulation | 2.08289591 |
| 19 | MP0010329_abnormal_lipoprotein_level | 1.90788275 |
| 20 | MP0005083_abnormal_biliary_tract | 1.86117701 |
| 21 | MP0003724_increased_susceptibility_to | 1.83901428 |
| 22 | MP0009379_abnormal_foot_pigmentation | 1.79412060 |
| 23 | MP0002876_abnormal_thyroid_physiology | 1.69094430 |
| 24 | MP0005075_abnormal_melanosome_morpholog | 1.66205050 |
| 25 | MP0005379_endocrine/exocrine_gland_phen | 1.61244260 |
| 26 | MP0004782_abnormal_surfactant_physiolog | 1.57437655 |
| 27 | MP0005332_abnormal_amino_acid | 1.54561598 |
| 28 | MP0009840_abnormal_foam_cell | 1.52768022 |
| 29 | MP0003011_delayed_dark_adaptation | 1.50590884 |
| 30 | MP0009764_decreased_sensitivity_to | 1.50498430 |
| 31 | MP0001666_abnormal_nutrient_absorption | 1.48256767 |
| 32 | MP0002132_abnormal_respiratory_system | 1.47627487 |
| 33 | MP0003806_abnormal_nucleotide_metabolis | 1.42269405 |
| 34 | MP0001764_abnormal_homeostasis | 1.35140604 |
| 35 | MP0003868_abnormal_feces_composition | 1.30984941 |
| 36 | MP0000579_abnormal_nail_morphology | 1.29213554 |
| 37 | MP0009785_altered_susceptibility_to | 1.27163563 |
| 38 | MP0005248_abnormal_Harderian_gland | 1.25096325 |
| 39 | MP0005647_abnormal_sex_gland | 1.23163933 |
| 40 | MP0003191_abnormal_cellular_cholesterol | 1.20695540 |
| 41 | MP0005084_abnormal_gallbladder_morpholo | 1.19971677 |
| 42 | MP0005409_darkened_coat_color | 1.19827494 |
| 43 | MP0002277_abnormal_respiratory_mucosa | 1.19485785 |
| 44 | MP0003718_maternal_effect | 1.14083653 |
| 45 | MP0010386_abnormal_urinary_bladder | 1.10654989 |
| 46 | MP0001835_abnormal_antigen_presentation | 1.08572482 |
| 47 | MP0002796_impaired_skin_barrier | 1.07803182 |
| 48 | MP0002118_abnormal_lipid_homeostasis | 1.04621371 |
| 49 | MP0005646_abnormal_pituitary_gland | 1.02249095 |
| 50 | MP0005408_hypopigmentation | 1.01003777 |
| 51 | MP0000015_abnormal_ear_pigmentation | 1.00612045 |
| 52 | MP0006276_abnormal_autonomic_nervous | 0.99558673 |
| 53 | MP0003938_abnormal_ear_development | 0.95853812 |
| 54 | MP0002163_abnormal_gland_morphology | 0.94454200 |
| 55 | MP0000613_abnormal_salivary_gland | 0.94429094 |
| 56 | MP0009765_abnormal_xenobiotic_induced | 0.91399535 |
| 57 | MP0000647_abnormal_sebaceous_gland | 0.90609702 |
| 58 | MP0001346_abnormal_lacrimal_gland | 0.90570471 |
| 59 | MP0002148_abnormal_hypersensitivity_rea | 0.89983350 |
| 60 | MP0000609_abnormal_liver_physiology | 0.88968661 |
| 61 | MP0000372_irregular_coat_pigmentation | 0.87948063 |
| 62 | MP0002638_abnormal_pupillary_reflex | 0.86918509 |
| 63 | MP0000026_abnormal_inner_ear | 0.86818843 |
| 64 | MP0003186_abnormal_redox_activity | 0.86241375 |
| 65 | MP0002098_abnormal_vibrissa_morphology | 0.85690355 |
| 66 | MP0001986_abnormal_taste_sensitivity | 0.84228977 |
| 67 | MP0005670_abnormal_white_adipose | 0.82803929 |
| 68 | MP0004142_abnormal_muscle_tone | 0.82435015 |
| 69 | MP0005174_abnormal_tail_pigmentation | 0.80796102 |
| 70 | MP0005171_absent_coat_pigmentation | 0.79969483 |
| 71 | MP0005645_abnormal_hypothalamus_physiol | 0.77623596 |
| 72 | MP0005671_abnormal_response_to | 0.76239108 |
| 73 | MP0005551_abnormal_eye_electrophysiolog | 0.76024860 |
| 74 | MP0009763_increased_sensitivity_to | 0.75758281 |
| 75 | MP0001790_abnormal_immune_system | 0.74871775 |
| 76 | MP0005387_immune_system_phenotype | 0.74871775 |
| 77 | MP0000427_abnormal_hair_cycle | 0.73160056 |
| 78 | MP0006082_CNS_inflammation | 0.72796357 |
| 79 | MP0008469_abnormal_protein_level | 0.72304015 |
| 80 | MP0002009_preneoplasia | 0.71528448 |
| 81 | MP0001984_abnormal_olfaction | 0.71155988 |
| 82 | MP0005025_abnormal_response_to | 0.70301035 |
| 83 | MP0002249_abnormal_larynx_morphology | 0.70217545 |
| 84 | MP0002254_reproductive_system_inflammat | 0.68472030 |
| 85 | MP0001486_abnormal_startle_reflex | 0.67899885 |
| 86 | MP0002060_abnormal_skin_morphology | 0.67653923 |
| 87 | MP0000538_abnormal_urinary_bladder | 0.66369529 |
| 88 | MP0002095_abnormal_skin_pigmentation | 0.65498659 |
| 89 | MP0001919_abnormal_reproductive_system | 0.65056925 |
| 90 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.62091547 |
| 91 | MP0002419_abnormal_innate_immunity | 0.58339695 |
| 92 | MP0005319_abnormal_enzyme/_coenzyme | 0.58097526 |
| 93 | MP0004742_abnormal_vestibular_system | 0.56014574 |
| 94 | MP0005636_abnormal_mineral_homeostasis | 0.54804798 |
| 95 | MP0002938_white_spotting | 0.53826257 |
| 96 | MP0001324_abnormal_eye_pigmentation | 0.51494207 |
| 97 | MP0001853_heart_inflammation | 0.51211240 |
| 98 | MP0001177_atelectasis | 0.50507192 |
| 99 | MP0002177_abnormal_outer_ear | 0.49678858 |
| 100 | MP0003880_abnormal_central_pattern | 0.49306020 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged partial thromboplastin time (HP:0003645) | 5.89812488 |
| 2 | Conjugated hyperbilirubinemia (HP:0002908) | 5.13975505 |
| 3 | Joint hemorrhage (HP:0005261) | 4.80308384 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 4.28976440 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.01280646 |
| 6 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.75067251 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.70531783 |
| 8 | Abnormality of methionine metabolism (HP:0010901) | 3.70007338 |
| 9 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.65904155 |
| 10 | Deep venous thrombosis (HP:0002625) | 3.61102297 |
| 11 | Epidermoid cyst (HP:0200040) | 3.42208371 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 3.35483487 |
| 13 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.30388949 |
| 14 | Renal cortical cysts (HP:0000803) | 3.23781355 |
| 15 | Chromsome breakage (HP:0040012) | 3.21678922 |
| 16 | 3-Methylglutaconic aciduria (HP:0003535) | 3.08610100 |
| 17 | Abnormality of the axillary hair (HP:0100134) | 3.02235345 |
| 18 | Abnormality of secondary sexual hair (HP:0009888) | 3.02235345 |
| 19 | Hypophosphatemic rickets (HP:0004912) | 2.92595485 |
| 20 | Xanthomatosis (HP:0000991) | 2.85076684 |
| 21 | Parakeratosis (HP:0001036) | 2.80648246 |
| 22 | Hyperglycinemia (HP:0002154) | 2.76088454 |
| 23 | Fat malabsorption (HP:0002630) | 2.68869249 |
| 24 | Fair hair (HP:0002286) | 2.65733997 |
| 25 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.63640834 |
| 26 | Hyperlipoproteinemia (HP:0010980) | 2.54992849 |
| 27 | Duplicated collecting system (HP:0000081) | 2.48553792 |
| 28 | Complement deficiency (HP:0004431) | 2.48195478 |
| 29 | Renal Fanconi syndrome (HP:0001994) | 2.37041163 |
| 30 | Vascular calcification (HP:0004934) | 2.31898295 |
| 31 | Hypolipoproteinemia (HP:0010981) | 2.28730476 |
| 32 | Abnormality of serum amino acid levels (HP:0003112) | 2.27244632 |
| 33 | Methylmalonic acidemia (HP:0002912) | 2.26176135 |
| 34 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.25991765 |
| 35 | Abnormality of the renal collecting system (HP:0004742) | 2.25548672 |
| 36 | Conical tooth (HP:0000698) | 2.25063243 |
| 37 | Hypochromic microcytic anemia (HP:0004840) | 2.23423721 |
| 38 | Abnormality of the common coagulation pathway (HP:0010990) | 2.22896478 |
| 39 | Reticulocytopenia (HP:0001896) | 2.22596245 |
| 40 | Enlarged kidneys (HP:0000105) | 2.18670410 |
| 41 | Hyperglycinuria (HP:0003108) | 2.16735665 |
| 42 | Chronic hepatic failure (HP:0100626) | 2.15642027 |
| 43 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.14400514 |
| 44 | Abnormality of glycine metabolism (HP:0010895) | 2.14400514 |
| 45 | Steatorrhea (HP:0002570) | 2.09036260 |
| 46 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.08999593 |
| 47 | Hyperventilation (HP:0002883) | 2.08160592 |
| 48 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.08052197 |
| 49 | Cerebral edema (HP:0002181) | 2.07578736 |
| 50 | Delayed CNS myelination (HP:0002188) | 2.06809677 |
| 51 | Menorrhagia (HP:0000132) | 2.06377325 |
| 52 | Dry hair (HP:0011359) | 2.03903942 |
| 53 | Abnormal biliary tract physiology (HP:0012439) | 2.03219168 |
| 54 | Bile duct proliferation (HP:0001408) | 2.03219168 |
| 55 | Pruritus (HP:0000989) | 2.03029052 |
| 56 | Hyperammonemia (HP:0001987) | 2.02275054 |
| 57 | Gingival bleeding (HP:0000225) | 2.01046371 |
| 58 | Rickets (HP:0002748) | 2.01027593 |
| 59 | Hyperbilirubinemia (HP:0002904) | 2.00719132 |
| 60 | Generalized hypopigmentation of hair (HP:0011358) | 2.00044165 |
| 61 | Decreased central vision (HP:0007663) | 1.98935717 |
| 62 | Osteomalacia (HP:0002749) | 1.97868682 |
| 63 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.94233095 |
| 64 | Abnormality of the renal cortex (HP:0011035) | 1.92788205 |
| 65 | Metabolic acidosis (HP:0001942) | 1.92581927 |
| 66 | Hypercholesterolemia (HP:0003124) | 1.92414968 |
| 67 | Abnormality of urine glucose concentration (HP:0011016) | 1.91983403 |
| 68 | Glycosuria (HP:0003076) | 1.91983403 |
| 69 | Alveolar cell carcinoma (HP:0006519) | 1.91481341 |
| 70 | Prostate neoplasm (HP:0100787) | 1.91210686 |
| 71 | Lethargy (HP:0001254) | 1.91062194 |
| 72 | Renal tubular dysfunction (HP:0000124) | 1.87851914 |
| 73 | Gangrene (HP:0100758) | 1.87435847 |
| 74 | Hypoglycemic seizures (HP:0002173) | 1.87138875 |
| 75 | Hypoglycemic coma (HP:0001325) | 1.86332190 |
| 76 | Abnormality of homocysteine metabolism (HP:0010919) | 1.85129807 |
| 77 | Homocystinuria (HP:0002156) | 1.85129807 |
| 78 | Hypoalphalipoproteinemia (HP:0003233) | 1.84966559 |
| 79 | Cardiovascular calcification (HP:0011915) | 1.84623856 |
| 80 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.83916838 |
| 81 | Symptomatic seizures (HP:0011145) | 1.82958852 |
| 82 | Microvesicular hepatic steatosis (HP:0001414) | 1.82020556 |
| 83 | Abnormality of nucleobase metabolism (HP:0010932) | 1.81759780 |
| 84 | Abnormality of complement system (HP:0005339) | 1.81387767 |
| 85 | Abnormality of the intrinsic pathway (HP:0010989) | 1.81375965 |
| 86 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.81065808 |
| 87 | Dicarboxylic aciduria (HP:0003215) | 1.81065808 |
| 88 | Abnormality of vitamin metabolism (HP:0100508) | 1.78394918 |
| 89 | Glomerulonephritis (HP:0000099) | 1.78217069 |
| 90 | Cerebral palsy (HP:0100021) | 1.77377891 |
| 91 | Increased hepatocellular lipid droplets (HP:0006565) | 1.76367352 |
| 92 | Increased IgM level (HP:0003496) | 1.73651898 |
| 93 | Reduced antithrombin III activity (HP:0001976) | 1.73326419 |
| 94 | Abnormality of the prostate (HP:0008775) | 1.72452498 |
| 95 | Ketosis (HP:0001946) | 1.71279391 |
| 96 | Lipid accumulation in hepatocytes (HP:0006561) | 1.70079923 |
| 97 | Tubulointerstitial nephritis (HP:0001970) | 1.69650968 |
| 98 | Septo-optic dysplasia (HP:0100842) | 1.69521846 |
| 99 | Aplasia of the musculature (HP:0100854) | 1.69184651 |
| 100 | Abnormality of renal resorption (HP:0011038) | 1.68202577 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK16 | 5.08368795 |
| 2 | CASK | 3.46769321 |
| 3 | INSRR | 2.85159460 |
| 4 | ZAK | 2.79378016 |
| 5 | IRAK3 | 2.78769558 |
| 6 | TLK1 | 2.70208355 |
| 7 | NUAK1 | 2.55929164 |
| 8 | MAP3K14 | 2.53356145 |
| 9 | IRAK4 | 2.32926270 |
| 10 | TXK | 2.26648455 |
| 11 | ADRBK2 | 1.80323201 |
| 12 | GRK1 | 1.77225320 |
| 13 | EIF2AK2 | 1.76638979 |
| 14 | AKT3 | 1.71035861 |
| 15 | TIE1 | 1.70465814 |
| 16 | PRPF4B | 1.66454344 |
| 17 | BLK | 1.62597179 |
| 18 | BCKDK | 1.56573982 |
| 19 | YES1 | 1.53920800 |
| 20 | TNIK | 1.53619866 |
| 21 | GRK7 | 1.51036990 |
| 22 | BMPR1B | 1.49863345 |
| 23 | TAOK3 | 1.48508924 |
| 24 | PINK1 | 1.39606766 |
| 25 | BMPR2 | 1.38351907 |
| 26 | MKNK2 | 1.34829355 |
| 27 | IRAK1 | 1.32570449 |
| 28 | IRAK2 | 1.30633982 |
| 29 | SRPK1 | 1.29599909 |
| 30 | MUSK | 1.23977612 |
| 31 | CDK3 | 1.19498190 |
| 32 | VRK1 | 1.18928375 |
| 33 | NME2 | 1.16612999 |
| 34 | LATS1 | 1.10538457 |
| 35 | MAP2K7 | 1.06212051 |
| 36 | TNK2 | 1.05650503 |
| 37 | PKN1 | 1.04399373 |
| 38 | MST1R | 1.03414638 |
| 39 | ERBB4 | 0.98478439 |
| 40 | MAPK15 | 0.98433532 |
| 41 | IKBKB | 0.94910188 |
| 42 | NLK | 0.94112239 |
| 43 | TEC | 0.92818643 |
| 44 | FGFR4 | 0.89243231 |
| 45 | PBK | 0.89164412 |
| 46 | IKBKE | 0.86746802 |
| 47 | EPHB2 | 0.80738794 |
| 48 | PIK3CG | 0.78949555 |
| 49 | CLK1 | 0.78897979 |
| 50 | NEK6 | 0.78762316 |
| 51 | STK38L | 0.78035930 |
| 52 | MAPK13 | 0.72272951 |
| 53 | SGK2 | 0.71841244 |
| 54 | MKNK1 | 0.71044087 |
| 55 | DYRK2 | 0.70392714 |
| 56 | PLK4 | 0.67989109 |
| 57 | PRKCE | 0.66781092 |
| 58 | TYK2 | 0.65520553 |
| 59 | CHUK | 0.63132636 |
| 60 | CSNK1A1L | 0.61639001 |
| 61 | CSNK1G1 | 0.60545723 |
| 62 | LYN | 0.60290570 |
| 63 | JAK1 | 0.57511817 |
| 64 | EPHA4 | 0.54440230 |
| 65 | EPHA3 | 0.52656684 |
| 66 | ERBB3 | 0.51856690 |
| 67 | MST4 | 0.49918445 |
| 68 | TAOK2 | 0.49856611 |
| 69 | PRKCQ | 0.49302404 |
| 70 | PRKG1 | 0.46589455 |
| 71 | CAMK2A | 0.45012983 |
| 72 | RPS6KA5 | 0.43249760 |
| 73 | CSNK1G3 | 0.42604385 |
| 74 | EIF2AK1 | 0.42478233 |
| 75 | MAPK11 | 0.42338508 |
| 76 | FRK | 0.40797962 |
| 77 | ADRBK1 | 0.40788303 |
| 78 | DYRK1A | 0.40429433 |
| 79 | PRKACA | 0.39930094 |
| 80 | ABL2 | 0.39552076 |
| 81 | STK24 | 0.36869555 |
| 82 | SYK | 0.36676411 |
| 83 | PIK3CA | 0.36479613 |
| 84 | CAMK2G | 0.36204483 |
| 85 | PRKCG | 0.35844428 |
| 86 | MAPK4 | 0.34752623 |
| 87 | PRKAA2 | 0.34092374 |
| 88 | MAPK7 | 0.33965603 |
| 89 | MARK1 | 0.33863512 |
| 90 | PRKCD | 0.33499114 |
| 91 | BTK | 0.33173858 |
| 92 | CSNK1A1 | 0.32705660 |
| 93 | SGK494 | 0.32664559 |
| 94 | SGK223 | 0.32664559 |
| 95 | SIK3 | 0.32348782 |
| 96 | PRKCA | 0.31274684 |
| 97 | MAP2K6 | 0.31250506 |
| 98 | ABL1 | 0.30874198 |
| 99 | CAMK2B | 0.29715907 |
| 100 | CSNK2A1 | 0.29588076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.68399291 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.68148218 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.55934178 |
| 4 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.49171294 |
| 5 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.47771543 |
| 6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.45109757 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.39787150 |
| 8 | Retinol metabolism_Homo sapiens_hsa00830 | 2.38344334 |
| 9 | Histidine metabolism_Homo sapiens_hsa00340 | 2.35159611 |
| 10 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.19481529 |
| 11 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.16982549 |
| 12 | Peroxisome_Homo sapiens_hsa04146 | 2.16933246 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.13758296 |
| 14 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.13044277 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.12016364 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.99799405 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.95551656 |
| 18 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.94414721 |
| 19 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.93508891 |
| 20 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.88938017 |
| 21 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.87839767 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.86800423 |
| 23 | ABC transporters_Homo sapiens_hsa02010 | 1.76983371 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.75823305 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.73678662 |
| 26 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.67262751 |
| 27 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.63158300 |
| 28 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.59234675 |
| 29 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.56203697 |
| 30 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.55812856 |
| 31 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.55414310 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.54825211 |
| 33 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.47612746 |
| 34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.43389927 |
| 35 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.42927435 |
| 36 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.42419330 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.39172469 |
| 38 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.36777271 |
| 39 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.31426468 |
| 40 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.22533932 |
| 41 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.18353213 |
| 42 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.17558236 |
| 43 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.16151432 |
| 44 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.13345772 |
| 45 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.10646310 |
| 46 | Ribosome_Homo sapiens_hsa03010 | 1.09966066 |
| 47 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.09100454 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.07520880 |
| 49 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.04196433 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02254586 |
| 51 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.00172906 |
| 52 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.98350707 |
| 53 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.97934775 |
| 54 | Allograft rejection_Homo sapiens_hsa05330 | 0.94376302 |
| 55 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.90724190 |
| 56 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.90405393 |
| 57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.87552800 |
| 58 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.86569330 |
| 59 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.86497233 |
| 60 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.78447276 |
| 61 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.75984340 |
| 62 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.74756834 |
| 63 | Bile secretion_Homo sapiens_hsa04976 | 0.71040892 |
| 64 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.67318343 |
| 65 | Metabolic pathways_Homo sapiens_hsa01100 | 0.66832309 |
| 66 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.66273895 |
| 67 | Homologous recombination_Homo sapiens_hsa03440 | 0.65854325 |
| 68 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.64713271 |
| 69 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.63755445 |
| 70 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.62508581 |
| 71 | Protein export_Homo sapiens_hsa03060 | 0.62291485 |
| 72 | Phototransduction_Homo sapiens_hsa04744 | 0.61865508 |
| 73 | Nicotine addiction_Homo sapiens_hsa05033 | 0.61571355 |
| 74 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.59345373 |
| 75 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.53598252 |
| 76 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.52844230 |
| 77 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.52380722 |
| 78 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.51103407 |
| 79 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.49887165 |
| 80 | Asthma_Homo sapiens_hsa05310 | 0.46981968 |
| 81 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.44400965 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.39890380 |
| 83 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.39486449 |
| 84 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.36190231 |
| 85 | Lysine degradation_Homo sapiens_hsa00310 | 0.35965641 |
| 86 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.35716219 |
| 87 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.35489158 |
| 88 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30991178 |
| 89 | Sulfur relay system_Homo sapiens_hsa04122 | 0.30979018 |
| 90 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.30810963 |
| 91 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.29125162 |
| 92 | Alzheimers disease_Homo sapiens_hsa05010 | 0.28923573 |
| 93 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.27998705 |
| 94 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.27422003 |
| 95 | RNA polymerase_Homo sapiens_hsa03020 | 0.26338702 |
| 96 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.25252486 |
| 97 | * Taste transduction_Homo sapiens_hsa04742 | 0.22114498 |
| 98 | Malaria_Homo sapiens_hsa05144 | 0.22050147 |
| 99 | Measles_Homo sapiens_hsa05162 | 0.20259867 |
| 100 | Purine metabolism_Homo sapiens_hsa00230 | 0.20125912 |

